Ammonia ( DrugBank: Ammonia )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 6 | パーキンソン病 | 1 |
| 296 | 胆道閉鎖症 | 1 |
6. パーキンソン病
臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00775853 (ClinicalTrials.gov) | May 27, 2009 | 17/10/2008 | Biomarkers of Risk of Parkinson Disease | Biomarkers of Risk of Parkinson Disease | Parkinson Disease;Autonomic Nervous System Diseases;Pure Autonomic Failure | Drug: 6-[18F]Fluorodopamine;Drug: 6-[18F]Fluorodopa;Drug: 13N-Ammonia | National Institute of Neurological Disorders and Stroke (NINDS) | NULL | Completed | 18 Years | 70 Years | All | 89 | United States |
296. 胆道閉鎖症
臨床試験数 : 71 / 薬物数 : 70 - (DrugBank : 39) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 60
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100044533 | 2021-06-01 | 2021-03-23 | Multicenter study of non-invasive diagnostic scoring system for biliary atresia | Multicenter study of non-invasive diagnostic scoring system for biliary atresia | Biliary atresia | Gold Standard:Intraoperative cholangiography;Index test:Non-invasive diagnostic scoring system for biliary atresia (Biochemicaltests, blood routine, CRP, blood ammonia, AFP, hepatobiliary B ultrasound); | Children's Hospital Affiliated to Zhejiang University Medical College | NULL | Recruiting | Both | Target condition:200;Difficult condition:0 | China |